His primary scientific interests are in Peritoneal dialysis, Internal medicine, Surgery, Dialysis and Hemodialysis. His work deals with themes such as Creatinine, Peritonitis and Intensive care medicine, which intersect with Peritoneal dialysis. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Endocrinology and Peritoneum.
His research integrates issues of Blood pressure, Serum albumin and Urology in his study of Surgery. His studies deal with areas such as Cardiology, Relative risk, Nephrology and Risk factor as well as Dialysis. His Hemodialysis research includes themes of Survival rate, Mortality rate, Renal replacement therapy, Hazard ratio and Prospective cohort study.
His primary areas of study are Peritoneal dialysis, Internal medicine, Surgery, Dialysis and Urology. His Peritoneal dialysis research is multidisciplinary, incorporating perspectives in Creatinine, Peritonitis, Peritoneum and Intensive care medicine. His Internal medicine study combines topics in areas such as Gastroenterology and Endocrinology.
His work on Continuous ambulatory peritoneal dialysis, Peritoneal membrane and Complication is typically connected to Fluid transport as part of general Surgery study, connecting several disciplines of science. Raymond T. Krediet combines subjects such as Hemodialysis, Renal replacement therapy, Proportional hazards model, Hazard ratio and Prospective cohort study with his study of Dialysis. His study in Urology is interdisciplinary in nature, drawing from both Dialysis solutions, Icodextrin and Renal function.
Peritoneal dialysis, Urology, Internal medicine, Dialysis and Renal function are his primary areas of study. His study on Peritoneal dialysis is covered under Surgery. His Urology research incorporates elements of Creatinine, Dialysis solutions and Peritoneal dialysis solutions.
The various areas that he examines in his Internal medicine study include Gastroenterology, Endocrinology and Intensive care medicine. Raymond T. Krediet has researched Dialysis in several fields, including End stage renal disease, Hemodialysis, Cohort and Hazard ratio, Confidence interval. His research investigates the connection between Renal function and topics such as Kidney disease that intersect with issues in Lead time bias.
Raymond T. Krediet spends much of his time researching Peritoneal dialysis, Internal medicine, Dialysis, Surgery and Hemodialysis. His Peritoneal dialysis research includes themes of Urology and Pathology. As part of his studies on Internal medicine, Raymond T. Krediet often connects relevant subjects like Gastroenterology.
The various areas that Raymond T. Krediet examines in his Dialysis study include Predictive modelling, End stage renal disease, Transplantation and Cohort. The study of Surgery is intertwined with the study of Hazard ratio in a number of ways. The study incorporates disciplines such as Diabetes mellitus and Prospective cohort study in addition to Hemodialysis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate
Frans J. Hoek;Frits A. W. Kemperman;Raymond T. Krediet.
Nephrology Dialysis Transplantation (2003)
Performance of the Cockcroft-Gault, MDRD, and New CKD-EPI Formulas in Relation to GFR, Age, and Body Size
Wieneke Marleen Michels;Diana Carina Grootendorst;Marion Verduijn;Elise Grace Elliott.
Clinical Journal of The American Society of Nephrology (2010)
Predictors of the rate of decline of residual renal function in incident dialysis patients
Maarten A.M. Jansen;Augustinus A.M. Hart;Johanna C. Korevaar;Friedo W. Dekker.
Kidney International (2002)
Quality of life in patients on chronic dialysis: Self-assessment 3 months after the start of treatment☆
Maruschka P. Merkus;Kitty J. Jager;Friedo W. Dekker;Els W. Boeschoten.
American Journal of Kidney Diseases (1997)
Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: A randomized controlled trial
Johanna C. Korevaar;G.W. Feith;Friedo W. Dekker;Jeannette G. van Manen.
Kidney International (2003)
Relative Contribution of Residual Renal Function and Different Measures of Adequacy to Survival in Hemodialysis Patients: An analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2
Fabian Termorshuizen;Friedo W Dekker;Jeannette G van Manen;Johanna C Korevaar.
Journal of The American Society of Nephrology (2004)
The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the netherlands cooperative study on the adequacy of dialysis (Necosad)-2
Fabian Termorshuizen;Johanna C Korevaar;Friedo W Dekker;Jeannette G van Manen.
American Journal of Kidney Diseases (2003)
High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients
Nora Voormolen;Marlies Noordzij;Diana C. Grootendorst;Ivo Beetz.
Nephrology Dialysis Transplantation (2007)
Hemodialysis and Peritoneal Dialysis: Comparison of Adjusted Mortality Rates According to the Duration of Dialysis: Analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis 2
Fabian Termorshuizen;Johanna C. Korevaar;Friedo W. Dekker;Jeannette G. van Manen.
Journal of The American Society of Nephrology (2003)
The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients.
Marlies Noordzij;Johanna C. Korevaar;Elisabeth W. Boeschoten;Friedo W. Dekker.
American Journal of Kidney Diseases (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: